280 related articles for article (PubMed ID: 3143437)
1. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
Parving HH; Hommel E; Smidt UM
BMJ; 1988 Oct; 297(6656):1086-91. PubMed ID: 3143437
[TBL] [Abstract][Full Text] [Related]
2. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
Parving HH; Hommel E; Damkjaer Nielsen M; Giese J
BMJ; 1989 Aug; 299(6698):533-6. PubMed ID: 2507061
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Parving HH; Rossing P; Hommel E; Smidt UM
Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
[TBL] [Abstract][Full Text] [Related]
4. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
Rossing P; Hommel E; Smidt UM; Parving HH
Diabetologia; 1994 May; 37(5):511-6. PubMed ID: 8056190
[TBL] [Abstract][Full Text] [Related]
5. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
Mathiesen ER; Hommel E; Giese J; Parving HH
BMJ; 1991 Jul; 303(6794):81-7. PubMed ID: 1860008
[TBL] [Abstract][Full Text] [Related]
7. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
Parving HH; Hommel E; Jensen BR; Hansen HP
Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
[TBL] [Abstract][Full Text] [Related]
8. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.
Hommel E; Parving HH; Mathiesen E; Edsberg B; Damkjaer Nielsen M; Giese J
Br Med J (Clin Res Ed); 1986 Aug; 293(6545):467-70. PubMed ID: 3091164
[TBL] [Abstract][Full Text] [Related]
9. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
Parving HH; Larsen M; Hommel E; Lund-Andersen H
Diabetologia; 1989 Jul; 32(7):440-4. PubMed ID: 2680698
[TBL] [Abstract][Full Text] [Related]
10. Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy.
Elving LD; Wetzels JF; de Nobel E; Hoitsma AJ; Berden JH
Am J Kidney Dis; 1992 Dec; 20(6):559-63. PubMed ID: 1462982
[TBL] [Abstract][Full Text] [Related]
11. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus.
Cook J; Daneman D; Spino M; Sochett E; Perlman K; Balfe JW
J Pediatr; 1990 Jul; 117(1 Pt 1):39-45. PubMed ID: 2196359
[TBL] [Abstract][Full Text] [Related]
13. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
Marre M; Chatellier G; Leblanc H; Guyene TT; Menard J; Passa P
BMJ; 1988 Oct; 297(6656):1092-5. PubMed ID: 2848604
[TBL] [Abstract][Full Text] [Related]
14. Short term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics.
Romanelli G; Giustina A; Cimino A; Valentini U; Agabiti-Rosei E; Muiesan G; Giustina G
BMJ; 1989 Feb; 298(6669):284-8. PubMed ID: 2493897
[TBL] [Abstract][Full Text] [Related]
15. Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
Parving HH; Andersen AR; Smidt UM; Hommel E; Mathiesen ER; Svendsen PA
Br Med J (Clin Res Ed); 1987 Jun; 294(6585):1443-7. PubMed ID: 3111583
[TBL] [Abstract][Full Text] [Related]
16. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
Viberti G; Mogensen CE; Groop LC; Pauls JF
JAMA; 1994 Jan; 271(4):275-9. PubMed ID: 8295285
[TBL] [Abstract][Full Text] [Related]
17. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
Ratzmann KP; Raskovic M; Schimke E
Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
[TBL] [Abstract][Full Text] [Related]
18. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients.
Wiegmann TB; Herron KG; Chonko AM; MacDougall ML; Moore WV
Diabetes; 1992 Jan; 41(1):62-7. PubMed ID: 1727741
[TBL] [Abstract][Full Text] [Related]
20. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy.
Parving HH; Kastrup H; Smidt UM; Andersen AR; Feldt-Rasmussen B; Christiansen JS
Diabetologia; 1984 Dec; 27(6):547-52. PubMed ID: 6442240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
